Quantbot Technologies’s Catalyst Pharmaceutical CPRX Stock Holding History

Quantbot Technologies’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.4K	Buy	1,429 +548	+62%	+$13.1K	﹤0.01%	1448
2025 Q4	$20.6K	Sell	881 -2,283	-72%	-$50.9K	﹤0.01%	1566
2025 Q3	$62.3K	Sell	3,164 -14,739	-82%	-$303K	﹤0.01%	1496
2025 Q2	$388K	Buy	17,903 +1,224	+7%	+$28.9K	0.01%	1072
2025 Q1	$404K	Buy	16,679 +5,442	+48%	+$123K	0.01%	955
2024 Q4	$235K	Buy	11,237 +3,636	+48%	+$78.1K	0.01%	1021
2024 Q3	$151K	Buy	+7,601	New	+$141K	0.01%	1080
2023 Q1	–	Sell	-25,300	Closed	-$471K	–	1626
2022 Q4	$471K	Sell	25,300 -47,746	-65%	-$735K	0.03%	588
2022 Q3	$937K	Buy	+73,046	New	+$866K	0.07%	404
2022 Q2	–	Sell	-7,500	Closed	-$62K	–	1759
2022 Q1	$62K	Buy	+7,500	New	+$53K	0.01%	1151
2020 Q1	–	Sell	-800	Closed	-$3K	–	991
2019 Q4	$3K	Sell	800 -9,500	-92%	-$44.4K	﹤0.01%	1143
2019 Q3	$54K	Buy	+10,300	New	+$54.9K	0.01%	950

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Quantbot Technologies's CPRX Position: Q1 2026 in Review

Quantbot Technologies increased its Catalyst Pharmaceutical (CPRX) stake by 62% in Q1 2026, buying an estimated $13.1K and bringing the position to 1,429 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Quantbot Technologies first reported a position in CPRX in Q3 2019 and has held it in 12 quarters since. The position peaked at $937K in Q3 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Quantbot Technologies held 1,429 shares of Catalyst Pharmaceutical worth $35.4K as of Q1 2026.
Quantbot Technologies bought 548 Catalyst Pharmaceutical shares in Q1 2026, an estimated $13.1K.
Catalyst Pharmaceutical made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1448 holding.
Quantbot Technologies first reported a position in Catalyst Pharmaceutical in Q3 2019 and has held it in 12 quarters since.
Quantbot Technologies's Catalyst Pharmaceutical position peaked at $937K in Q3 2022.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.